Dedicated, Independent, & Investigator-Led Research Practice

• We combine scientific excellence with patient-centered research.
• Disorders and Conditions of the CNS are our core expertise. 
• Our experienced team, state-of-the-art facilities, and commitment to compliance make us an ideal partner for pharmaceutical sponsors looking for efficient, reliable, and ethically sound research execution.

• Specialization in a broad set of CNS indications (including general psychiatric diagnoses, substance use disorders, and eating disorders), various pain disorders, migraines, obesity, and general health. 
• Experience with Phase I-IV studies, novel therapeutics, digital interventions, and biomarker research.
• Proficiency in rating scales (e.g., MADRS, HAM-D, GAD-7, EDE-Q) for psychiatric clinical trials.

• Led by Donald J. Garcia, Jr., MD, a board-certified psychiatrist with extensive clinical trial experience.
• Dedicated research coordinators, raters, and investigators trained in Good Clinical Practice (GCP) and FDA regulations.
• Strong relationships with local healthcare providers and mental health professionals, ensuring diverse patient recruitment.

• Access to a large and diverse patient population through referral networks and direct outreach.
• Strong digital and community-based recruitment strategies, including social media, online advertising, and physician referrals.
• High retention rates due to patient-centric study designs and engagement strategies.

• Dedicated clinical research space with exam rooms, monitoring areas, and secure drug storage.
• On-site laboratory processing and EEG, ECG, and pharmacokinetic sampling capabilities.
• Fully equipped electronic data capture (EDC) and remote monitoring capabilities.

• Fully IRB-compliant with a strong track record of audit readiness.
• Strict adherence to FDA, ICH-GCP, and HIPAA guidelines.
• Efficient contract and budget negotiation, ensuring fast study start-up times.

• Transparent real-time data sharing and open communication with sponsors and CROs.
• Flexible scheduling and rapid enrollment capabilities.
• Dedicated study startup specialists to expedite regulatory approvals and site activation.

We have successfully partnered with leading pharmaceutical companies, CROs, and biotech firms in conducting psychiatric clinical trials. Our site’s expertise in mental health research has contributed to groundbreaking treatments and novel therapeutic approaches.